Risk-adapted preemptive therapy for cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation.
Mori
Takehiko
T
Aisa
Yoshinobu
Y
Nakazato
Tomonori
T
Ikeda
Yasuo
Y
Okamoto
Shinichiro
S
D000998:Antiviral Agents / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000517:prevention & control*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods; D006801:Humans; D011292:Premedication; D012307:Risk Factors; D014184:Transplantation, Homologous
D000998:Antiviral Agents